These results shows that billions of dollars in productivity gains can be acquired by incorporating organ-chip technology into the process of drug development without brutalizing Animals.
Congratulations to Emulate for publishing their landmark study today in Nature Communications Medicine validating Organ-on-a-Chip technology for predictive toxicology in preclinical development. This comprehensive study shows the superiority of Liver-Chips in predicting drug liver toxicity in humans, as compared to existing standard methods like animal testing.
The Emulate human Liver-Chip correctly identified 87% of drugs that caused serious liver toxicity and deaths in patients despite passing through animal testing.
Liver toxicity is one of the top safety problems that lead to drug failures and causes significant human harm. This Liver-Chip technology can save numerous lives if incorporated into the drug development process and can replace ineffective animal testing.
The study also presents the strongest economic argument to date. It shows that billions of dollars in productivity gains can be acquired by incorporating the technology into the process of drug development.